XML 140 R115.htm IDEA: XBRL DOCUMENT
v3.24.2

Fair value measurements | 3 Months Ended | 12 Months Ended
--- | --- | ---
Mar. 31, 2024 | Dec. 31, 2023
Fair value measurements |  |
Fair value measurements | Note 16 — Fair value measurements The Company’s financial instruments consist of cash and cash equivalents, accounts receivable, and accounts payable where the carrying value approximates fair value due to the short-term nature of each instrument. The Company uses valuation approaches that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible. A three-tiered hierarchy is established as a basis for considering such assumptions and for inputs used in the valuation methodologies in measuring fair value. This hierarchy requires that the Company use observable market data, when available, and minimize the use of unobservable inputs when determining fair value:
| ● | Level 1: observable inputs such as quoted prices in active markets;
| ● | Level 2: inputs other than the quoted prices in active markets that are observable either directly or indirectly; and
| ● | Level 3: unobservable inputs in which there is little or no market data, which requires that the Company develop its own assumptions.
The Company’s financial instruments consist of cash and cash equivalents, accounts receivable and accounts payables, where the carrying amount approximates fair value due to the short-term nature of each instrument. The fair value of the convertible note was determined using the following significant unobservable inputs. ​
​ | ​ | ​ | ​ | ​
Fair Value Assumption – Financing Note |  | March 31, 2024 |
Principal | ​ | $ | 2,330 | ​
Discount rate | ​ |  | 25.00 | %
Note term | ​ |  | 2.72 | years
Stock Price | ​ | $ | 2.26 | ​
Maturity date | ​ |  | 12/19/2026 | ​
Risk rate | ​ |  | 4.34 | %
Volatility | ​ |  | 36.33 | %
​ The fair value of the Financing Notes as of March 31, 2024, is $1,695 and was classified as Level 3 within the fair value hierarchy. The fair value of the Company’s outstanding warrants as of March 31, 2024, is $20 and was classified as Level 3 within the fair value hierarchy. ​
​ | ​ | ​ | ​ | ​
​ | ​ | March 31, | ​
Fair Value Assumption – Warrants |  | 2024 |
Exercise Price | ​ | $ | 11.50 | ​
Warrant term | ​ | ​ | 4.72 | years
Maturity date |  | ​ | 12/19/2028 | ​
Stock Price |  | $ | 2.26 | ​
Risk rate |  | ​ | 4.13 | %
Volatility | ​ | ​ | 37.68 | %
​ | Note 17 — Fair Value Measurements The Company’s financial instruments consist of cash and cash equivalents, accounts receivable, earn-outs, and accounts payable where the carrying value approximates fair value due to the short-term nature of each instrument. The Company uses valuation approaches that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible. A three-tiered hierarchy is established as a basis for considering such assumptions and for inputs used in the valuation methodologies in measuring fair value. This hierarchy requires that the Company use observable market data, when available, and minimize the use of unobservable inputs when determining fair value:
| ● | Level 1: observable inputs such as quoted prices in active markets;
| ● | Level 2: inputs other than the quoted prices in active markets that are observable either directly or indirectly; and
| ● | Level 3: unobservable inputs in which there is little or no market data, which requires that the Company develop its own assumptions.
The Company’s financial instruments consist of cash and cash equivalents, accounts receivables and accounts payables, where the carrying amount approximates fair value due to the short-term nature of each instrument. On October 9, 2020, the Company implemented the Plan pursuant to which the Company’s Board of Directors may grant stock options to employees and non-employees. The common stock granted as part of the Plan were recorded in equity and classified as Level 3 within the fair value hierarchy. On December 19, 2023, prior to the closing of the Business Combination, the Board of Directors of Legacy ICI authorized that the shares of common stock which were subject to the Transaction RSU Awards would be delivered in accordance with the terms of the Restricted Stock Unit Agreement. All Transaction RSU Awards issued were valued using a fair value of $6.82, which was the closing share price of our common stock on that date. The common stock granted as part of the Plan were recorded in equity and classified as Level 1 within the fair value hierarchy. The convertible note was valued using a probability-weighted expected return method (“PWERM”) based on the probabilities of different potential outcomes for the note. The fair value of the convertible note was determined using the following significant unobservable inputs. ​
​ | ​ | ​ | ​ | ​
Fair Value Assumption – Financing Note |  | December 31, 2023 |
Principal | ​ | $ | 6,805 | ​
Discount rate | ​ |  | 20.00 | %
Note term | ​ |  | 2.97 years | ​
Stock Price | ​ | $ | 3.35 | ​
Maturity date | ​ |  | 12/19/2026 | ​
Risk rate | ​ |  | 3.92 | %
Volatility | ​ |  | 32.49 | %
​ The fair value of the Financing Notes as of December 31, 2023 is $5,695 and is classified as Level 3 within the fair value hierarchy. The fair value of the Company’s outstanding warrants as of December 31, 2023 and is classified as Level 1 within the fair value hierarchy. ​
​ | ​ | ​ | ​ | ​
Fair Value Assumption – Warrants |  | December 31, 2023 |
Exercise Price | ​ | $ | 11.50 | ​
Warrant term | ​ | ​ | 4.97 years | ​
Maturity date | ​ |  | 12/19/2028 | ​
Stock Price | ​ | $ | 3.35 | ​
Risk rate | ​ |  | 3.75 | %
Volatility | ​ |  | 33.29 | %
​

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_FairValueDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration